Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Clinical Therapeutics|April 8, 2015
New FDA-Approved Disease-Modifying Therapies for Multiple SclerosisClayton English, Joseph J AloiPharmacotherapy|September 20, 2011
Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled TrialsCatherine A Harrington, Clayton EnglishInternational Clinical Psychopharmacology|August 14, 2010
Tolerability of paliperidone: a meta-analysis of randomized, controlled trialsCatherine A Harrington, Clayton EnglishFrontiers in Psychiatry|October 16, 2025
Nefazodone shortage in the United States: analysis of drug switching and utilizationAshley Tabah, Julia Fox, Clayton EnglishExploratory Research in Clinical and Social Pharmacy|March 27, 2026
First-generation antipsychotic shortages in the United States: Utilization and switching patternsAshley Tabah, Neel Swamy, Clayton EnglishBipolar Disorders|July 1, 2026
Psychotropic Prescribing Patterns Among Bipolar-I Patients Prior to Established Bipolar-I Disorder DiagnosisFilmon Haile, Clayton English, Kyueun LeeJournal of Gerontological Nursing|May 29, 2025
Xanomeline/Trospium Combination for Schizophrenia: Treatment Considerations for Older AdultsClayton English, Kaela Bergeron, Leigh Ann MikeP & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2017
Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal WomenClayton English, Anne Muhleisen, Jose A ReyPharmacy Practice|December 25, 2013
Prevalence of hazardous alcohol use among pharmacy students at nine U.S. schools of pharmacyClayton English, Jose A Rey, Lauren S SchlesselmanNeuropsychiatric Disease and Treatment|May 10, 2012
The role of paliperidone extended release for the treatment of bipolar disorderJehan Marino, Clayton English, Joshua Caballero, et al.Pageof 2